On his twitter feed, Carrick seems very positive on Adrian... too much for it to be negative results in my opinion. But I'm an optimist!
Can we just clarify exactly what we are about to find out on Wed morning then...
Whether the Carrick institute has, in early findings on its trial of the Mente headset, found that the technology provides a greater attention span, focus and improved communication in the test group, of more than 50%(?).
What does it actually mean? Would that be enough for the European sales teams to go hard in marketing the product?
Next stage would be final findings from Carrick (do we know which month?), and then application for FDA clearance next year.
Is that about right?
NTI Price at posting:
16.5¢ Sentiment: Hold Disclosure: Held
